C3 BIOTECHNOLOGIES LIMITED

No Analysis Available

Get instant AI-powered insights about this company's financial health, risks, and trends.

Order Analysis - £10

Who controls this company?

Mr Michael Hyde Smith

Correspondence address
"La Croute De Bas",, Route De St. Andre,, St. Andrews,, United Kingdom, GY6 8TX
Date of birth
April 1958
Notified on
2016-06-04
Nationality
British
Country of residence
United Kingdom
Nature of control
Owns more than 75% of the company's shares
Has more than 75% of the voting rights in the company

Mr Michael Hyde Smith

Correspondence address
"La Croute De Bas",, Route De St. Andre,, St. Andrews,, United Kingdom, GY6 8TX
Date of birth
April 1958
Notified on
2016-04-25
Nationality
British
Country of residence
United Kingdom
Nature of control
Has significant influence or control

Mr Michael Hyde Smith

Correspondence address
"La Croute De Bas",, Route De St. Andre,, St. Andrews,, United Kingdom, GY6 8TX
Date of birth
April 1958
Notified on
2016-04-25
Nationality
British
Country of residence
United Kingdom
Nature of control
Has significant influence or control

Professor Nigel Shaun Scrutton

Correspondence address
28 Chardin Avenue, Marple Bridge, United Kingdom, SK6 5DN
Date of birth
April 1964
Notified on
2016-06-04
Nationality
British
Country of residence
United Kingdom
Nature of control
Owns between 25% and 50% of the company's shares
Has between 25% and 50% of the voting rights in the company
Right to appoint and remove directors as a member of a firm

Professor Nigel Shaun Scrutton

HISTORIC INFORMATION
Ceased on
2016-04-25
Correspondence address
28 Chardin Avenue, Marple Bridge, United Kingdom, SK6 5DN
Date of birth
April 1964
Notified on
2016-04-25
Nationality
British
Country of residence
United Kingdom
Nature of control
Has significant influence or control


More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company